Assembly Biosciences ASMB Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Assembly Biosciences's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Assembly Biosciences's financing cash flow?
- Assembly Biosciences (ASMB) reported financing cash flow of $149K in Q1 2026.
- How has Assembly Biosciences's financing cash flow changed year-over-year?
- Assembly Biosciences's financing cash flow decreased by 92.2% year-over-year, from $1.92M to $149K.
- What is the long-term trend for Assembly Biosciences's financing cash flow?
- Over 4 years (2021 to 2025), Assembly Biosciences's financing cash flow has grown at a 34.7% compound annual growth rate (CAGR), from $53.06M to $174.67M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.